News

September 15, 2017

Abdominal Fat Increases Risk of Postmenopausal Women Developing Some Cancers, Study Suggests

News

Abdominal fat is a better predictor than body weight of postmenopausal women developing some types of cancer — but not ovarian cancer, according to a Danish study. It reported that women ... Read more

September 13, 2017

Mobile App Helps Ovarian Cancer Patients Monitor Tumor Markers

News

Australian charity Cherish Women’s Cancer Foundation is launching a new mobile app designed to give women battling ovarian cancer more control over their disease by allowing them to monitor their tumor markers in ... Read more

September 11, 2017September 11, 2017

Rubraca as Maintenance Therapy Seen to Aid Survival Without Disease Progression in Range of Patients

News

Rubraca (rucaparib) maintenance treatment significantly improved survival without further disease progression among ovarian cancer patients taking part in a Phase 3 clinical trial, researchers showed in a presentation at the ongoing European Society ... Read more

September 8, 2017September 8, 2017

Tumor DNA in Blood Used to Detect Many Early-stage Ovarian and Other Cancers in Study

News

Using a modern DNA sequencing technique, Johns Hopkins researchers have come one step closer to diagnosing early-stage cancer patients with a simple blood draw. The method reads free circulating DNA in ... Read more

September 6, 2017

Phase 1 Clinical Trial Is Assessing Cantrixil in Ovarian Cancer Patients Who Are Resistant to Chemo

News

Three Australian and two American cancer centers are spearheading the first clinical trial of Cantrixil, Novogen’s therapy to restore ovarian cancer patients’ sensitivity to chemotherapy. Associate Professor Jim Coward, an oncologist at ... Read more

September 1, 2017

Lynparza Maintenance Reduces Risk of Disease Progression in Advanced Ovarian Cancer Patients, SOLO-2 Trial Shows

News

Women with BRCA-mutated relapsed ovarian cancer whose tumors responded to platinum-based chemotherapy took significantly longer to see their disease progressing when given AstraZeneca’s Lynparza (olaparib) as a maintenance therapy, compared to placebo. In addition to ... Read more

August 30, 2017

Celsion to Present New Data from OVATION Trial at Ovarian Cancer Meeting

News

All newly diagnosed ovarian cancer patients enrolled in the OVATION Phase 1b trial (NCT02480374) to date benefited from the addition of GEN-1 to standard of care, according to Celsion, the drug’s developer. ... Read more

August 28, 2017

Cancer Research UK Tests Therapy for Advanced Ovarian, Other Cancers in Phase 1 Trial

News

An investigational therapy called LY3143921 hydrate will be tested for the first time in a large Phase 1 clinical trial for patients with advanced cancers, including ovarian cancer. The trial ... Read more

August 25, 2017

Most Women with History of Ovarian or Breast Cancer Are Not Receiving Recommended Genetic Tests, Study Finds

News

Genetic screening to detect mutations that can predispose women to the development of breast or ovarian cancer has available since the mid-1990s. However, more than 80 percent of women at ... Read more

August 23, 2017

Biotech Completes Dose Escalation Part of Phase 1 Study of COTI-2 in Gynecological Cancers

News

The dose escalation part of a Phase 1 trial evaluating COTI-2 in women with advanced gynecological cancers who did not respond to standard therapy has been completed, according to the ... Read more